GL1X · GenesisL1 explorer

MolNFT v1 · #106015 · protein

Human SIRT2 in complex with SIRREAL2 and NAD+

4RMG · NAD-dependent protein deacetylase sirtuin-2: “Human SIRT2 in complex with SIRREAL2 and NAD+”. X-ray diffraction, 3 ligands (3TE, NAD, ZN), 3 pockets (best druggability 0.75). MolNFT v1 #106015 on GenesisL1: 3D structure, binding…

PDB
4RMG
Type
protein
Length
297 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-2
EC
3.5.1.-
UniProt
Q8IXJ6
Ligands
3TE, NAD, ZN
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-)protein29741% helix, 17% strandQ8IXJ6

Ligands and binding sites

  • 3TE · 2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]-N-[5-(naphthalen-1-ylmethyl)-1,3-thiazol-2-yl]acetamide · ligand · chains A
  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16250.750.81483TE, NAD
21300.410.7527empty
3770.350.7619empty

Compared structures

  • 4RMG · Human Sirt2 in complex with SirReal2 and NAD+ · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8IXJ6 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-2 (Q8IXJ6) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.